XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases
批准号:
7012166
负责人:
Paul A. WATKINS
金额:
$33.4万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2008-01-31
关键词:
acyl coAadrenoleukodystrophyclinical researchdisease /disorder modelenzyme activityenzyme mechanismfatty acid metabolismfatty acid synthasegenetically modified animalshuman genetic material taghuman tissuelaboratory mouselaboratory ratlong chain fatty acidphenotypesex linked traittechnology /technique developmenttissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Acyl-CoA synthetases (ACS) occupy a central position in fatty acid metabolism. For incorporation into phospholipids, triglycerides, or cholesterol esters, elongation, desaturation, degradation by b-oxidation, or acylation of proteins, a fatty acid must first be activated to its CoA thioester. Despite this vital function, only recently have the precise roles in metabolism of the numerous mammalian ACSs begun to be investigated. We have grouped ACSs by amino acid sequence similarity into at least six families. Two human and mouse ACS families, the very long-chain ACS (VLACS) family and a recently discovered ACS family that includes the BG gene (mutated in the fruit fly mutant "bubblegum") contain enzymes capable of activating very long-chain fatty acids (VLCFA; containing >22 carbons). VLCFA are essential components of complex lipids, particularly in the brain, and maintenance of VLCFA homeostasis is critical to normal health. Thus, enzymes that control the fate of VLCFA by any of the pathways noted above are of central importance. VLCFA accumulate in plasma and tissues of patients with X-linked adrenoleukodystrophy (XALD), a severe, often fatal neurodegenerative disorder. Defective VLCFA degradation via peroxisomal b-oxidation and decreased VLACS activity in peroxisomes have been implicated in the biochemical pathology of XALD. However, the gene defective in XALD, ABCD1, encodes ALDP, a peroxisomal protein of the ATP-binding cassette transmembrane transporter superfamily that has no VLACS activity. The VLACS and BG families contain a total of 8 enzymes. To understand overall VLCFA homeostasis, we must therefore understand the specific function of each of these enzymes. Therefore, we propose: 1) to develop a novel and generally applicable ACS assay, 2) to investigate the specific biological roles of human VLACSs, and 3) to characterize the BG1 knockout mouse and to assess the role of BG1 in XALD. Results of these studies will have a significant impact on our understanding of how fatty acids are channeled into specific metabolic pathways. Furthermore, they will facilitate elucidation of the role of enzymes belonging to the VLACS or BG families in XALD.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase.
超长链酰基辅酶 A 合成酶的人类肝脏特异性同源物是胆酸盐:辅酶 A 连接酶。
DOI:
10.1074/jbc.c000015200
发表时间:
2000
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Steinberg,SJ, Mihalik,SJ, Kim,DG, Cuebas,DA, Watkins,PA]
通讯作者:
Watkins,PA
DOI:
10.1158/0008-5472.can-08-4689
发表时间:
2009-12-15
期刊:
Cancer research
影响因子:
11.2
作者:
[Pei Z, Sun P, Huang P, Lal B, Laterra J, Watkins PA]
通讯作者:
Watkins PA
Human liver-specific very-long-chain acyl-coenzyme A synthetase: cDNA cloning and characterization of a second enzymatically active protein.
人肝脏特异性超长链酰基辅酶 A 合成酶:第二种酶活性蛋白的 cDNA 克隆和表征。
DOI:
10.1006/mgme.1999.2883
发表时间:
1999
期刊:
Molecular genetics and metabolism.
影响因子:
--
作者:
[Steinberg,SJ, Wang,SJ, McGuinness,MC, Watkins,PA]
通讯作者:
Watkins,PA
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular
-
批准号:8259211
-
项目类别:
-
资助金额:$34.51万
-
财政年份:2009
-
负责人:Paul A. WATKINS
-
依托单位:
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular
-
批准号:8463259
-
项目类别:
-
资助金额:$33.31万
-
财政年份:2009
-
负责人:Paul A. WATKINS
-
依托单位:
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular
-
批准号:8067910
-
项目类别:
-
资助金额:$34.51万
-
财政年份:2009
-
负责人:Paul A. WATKINS
-
依托单位:
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular
-
批准号:7736241
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2009
-
负责人:Paul A. WATKINS
-
依托单位:
Brain Uptake and Utilization of Fatty Acids and Lipids
-
批准号:6838021
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2004
-
负责人:Paul A. WATKINS
-
依托单位:
DHA SYNTHESIS AND TRANSPORT IN PEX2-/-MOUSE
-
批准号:6536270
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2001
-
负责人:Paul A. WATKINS
-
依托单位:
XALD--ROLE OF VERY LONG CHAIN FATTY ACYL COA SYNTHETASES
-
批准号:6499411
-
项目类别:
-
资助金额:$29.19万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases
-
批准号:6849795
-
项目类别:
-
资助金额:$34.2万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
BRAIN FATTY ACID UPTAKE, UTILIZATION AND RELEVANCE TO PB
-
批准号:6070276
-
项目类别:
-
资助金额:$2.8万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
XALD--ROLE OF VERY LONG CHAIN FATTY ACYL COA SYNTHETASES
-
批准号:6151548
-
项目类别:
-
资助金额:$27.51万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
XALD--ROLE OF VERY LONG CHAIN FATTY ACYL COA SYNTHETASES
-
批准号:6351855
-
项目类别:
-
资助金额:$28.34万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
XALD--ROLE OF VERY LONG CHAIN FATTY ACYL COA SYNTHETASES
-
批准号:2757964
-
项目类别:
-
资助金额:$26.71万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases
-
批准号:6699670
-
项目类别:
-
资助金额:$34.2万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases
-
批准号:6631056
-
项目类别:
-
资助金额:$36.58万
-
财政年份:1999
-
负责人:Paul A. WATKINS
-
依托单位:
PHYTANIC ACID OXIDATION IN DISEASE & PEROXISOME ASSEMBLY
-
批准号:2152258
-
项目类别:
-
资助金额:$18.38万
-
财政年份:1996
-
负责人:Paul A. WATKINS
-
依托单位:
PHYTANIC ACID OXIDATION IN DISEASE & PEROXISOME ASSEMBLY
-
批准号:2414921
-
项目类别:
-
资助金额:$19.12万
-
财政年份:1996
-
负责人:Paul A. WATKINS
-
依托单位:
PHYTANIC ACID OXIDATION IN DISEASE & PEROXISOME ASSEMBLY
-
批准号:2701202
-
项目类别:
-
资助金额:$19.88万
-
财政年份:1996
-
负责人:Paul A. WATKINS
-
依托单位:
PHYTANIC ACID OXIDATION IN DISEASE & PEROXISOME ASSEMBLY
-
批准号:6089194
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1996
-
负责人:Paul A. WATKINS
-
依托单位:
海外基金